← Leaderboards
Jonathan S Lewin
Case Western Reserve University
$83,497,164
Attributed
$83,497,164
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $13.3M · FY2007–22$20M$15M$10M$5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$83,497,164 · 4
By mechanism
P51$81,551,237 · 1
S10$1,325,000 · 1
R01$620,927 · 1
M01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Case Western Reserve University
Same institution · by research overlap
- Jinming Gao$19,330,906
- Jeffrey L. Duerk$10,197,099
- Gerald M Saidel$2,176,661
- David A. Zidar$1,694,866
- Peter Scott Heeger$92,873,534
Others in their field
Top investigators on “Funding”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,479,940,681
- Leonard Freedman · Leidos Biomedical Research, Inc.$968,195,877
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Jeffrey P Krischer · University Of South Florida$358,470,093
Research focus
FundingNonhuman PrimateImmunologyBasePrimatesMemberUniversitiesCommunitiesPathologyNeurosciencesResearch PersonnelProgramsGeneticMedical SpecialtiesReportingGuidelinesBreedingGraduate StudentBehavioralBiologyGrantBiomedical ResearchFacultyMission
Grant awards (28)
Support of Yerkes National Primate Research Center$499,999
P51 · FY2022 · OD · contact PI
Emory National Primate Research Center$499,999
P51 · FY2022 · OD · contact PI
Emory National Primate Research Center$499,995
P51 · FY2022 · OD · contact PI
Emory National Primate Research Center$482,394
P51 · FY2022 · OD · contact PI
Support of Yerkes National Primate Research Center$10,751,414
P51 · FY2021 · OD · contact PI
Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesis$1,242,793
P51 · FY2021 · OD · contact PI
Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesis$784,482
P51 · FY2021 · OD · contact PI
Developing an NHP model for understanding the biological causes of long COVID-19 pathogenesis$499,999
P51 · FY2021 · OD · contact PI
Support of Yerkes National Primate Research Center$10,540,602
P51 · FY2020 · OD · contact PI
Support of Yerkes National Primate Research Center$499,999
P51 · FY2020 · OD · contact PI
Support of Yerkes National Primate Research Center$476,211
P51 · FY2020 · OD · contact PI
Support of Yerkes National Primate Research Center$454,656
P51 · FY2020 · OD · contact PI
Support of Yerkes National Primate Research Center$10,540,602
P51 · FY2019 · OD · contact PI
Support of Yerkes National Primate Research Center$499,999
P51 · FY2019 · OD · contact PI
Support of Yerkes National Primate Research Center$497,500
P51 · FY2019 · OD · contact PI
Support of Yerkes National Primate Research Center$10,540,602
P51 · FY2018 · OD · contact PI
Support of Yerkes National Primate Research Center$485,501
P51 · FY2018 · OD · contact PI
Support of Yerkes National Primate Research Center$10,013,573
P51 · FY2017 · OD · contact PI
Support of Yerkes National Primate Research Center$466,731
P51 · FY2017 · OD · contact PI
Support of Yerkes National Primate Research Center$10,540,602
P51 · FY2016 · OD · contact PI
Support of Yerkes National Primate Research Center$499,990
P51 · FY2016 · OD · contact PI
Support of Yerkes National Primate Research Center$9,510,024
P51 · FY2015 · OD · contact PI
Support of Yerkes National Primate Research Center$723,570
P51 · FY2015 · OD · contact PI
Coronary Atherosclerosis Evaluation by Arterial Wall MRI$620,927
R01 · FY2007 · HL · contact PI
4.7 T Small Aninal MR Imaging and Spectroscopy System$1,325,000
S10 · FY2002 · RR
MR GUIDED THERMAL ABLATION OF ABDOMINAL TUMORS$0
M01 · FY2002 · RR
MR GUIDED THERMAL ABLATION OF ABDOMINAL TUMORS$0
M01 · FY2001 · RR
MR GUIDED THERMAL ABLATION OF ABDOMINAL TUMORS$0
M01 · FY2000 · RR